{"organizations": [], "uuid": "86a70571a32765e36534b5c811c77680c0ea66f9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180215.html", "section_title": "Archive News &amp; Video for Thursday, 15 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-acorda-therapeutics-q4-adj-shr-061/brief-acorda-therapeutics-q4-adj-shr-0-61-idUSL8N1Q53XZ", "country": "US", "domain_rank": 408, "title": "BRIEF-Acorda Therapeutics Q4 Adj Shr $0.61", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.776, "site_type": "news", "published": "2018-02-15T19:29:00.000+02:00", "replies_count": 0, "uuid": "86a70571a32765e36534b5c811c77680c0ea66f9"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-acorda-therapeutics-q4-adj-shr-061/brief-acorda-therapeutics-q4-adj-shr-0-61-idUSL8N1Q53XZ", "ord_in_thread": 0, "title": "BRIEF-Acorda Therapeutics Q4 Adj Shr $0.61", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "acorda therapeutics inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "hare", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 15 (Reuters) - Acorda Therapeutics Inc:\n* Q4 REVENUE $188.4 MILLION * Q4 NON-GAAP EARNINGS PER SHARE $0.61\n* Q4 GAAP LOSS PER SHARE $3.70 * AMPYRA NET REVENUE IS EXPECTED TO BE $330 MILLION TO $350 MILLION IN 2018\n* RESEARCH AND DEVELOPMENT EXPENSES FOR FULL YEAR 2018 ARE EXPECTED TO BE $100 MILLION TO $110 MILLION Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-15T19:29:00.000+02:00", "crawled": "2018-02-16T17:08:23.029+02:00", "highlightTitle": ""}